Lazard Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $110K | Sell |
|
|||||
|
2024
Q3 | $947K | Sell |
|
|||||
|
2024
Q2 | $6.07M | Buy |
|
|||||
|
2024
Q1 | $1.08M | Buy |
|
|||||
|
2023
Q4 | $556K | Sell |
|
|||||
|
2023
Q3 | $827K | Buy |
|
|||||
|
2023
Q2 | $842K | Sell |
|
|||||
|
2023
Q1 | $2.55M | Buy |
|
|||||
|
2022
Q4 | $2.89M | Sell |
|
|||||
|
2022
Q3 | $7.08M | Buy |
|
|||||
|
2022
Q2 | $5.73M | Buy |
|
|||||
|
2022
Q1 | $2.9M | Sell |
|
|||||
|
2021
Q4 | $11.8M | Sell |
|
|||||
|
2021
Q3 | $34.6M | Buy |
|
|||||
|
2021
Q2 | $21M | Buy |
|
|||||
|
2021
Q1 | $2.57M | Buy |
|
|||||
|
2020
Q4 | $274K | Buy |
|